Reduced Mammography Screening for Breast Cancer among Women with Visual Impairment.

Ophthalmology
Annie M WuJoshua D Stein

Abstract

Timely mammography to screen for breast cancer in accordance with the United States Preventive Services Task Force (USPSTF) recommendations can reduce morbidity and mortality substantially. This study assessed whether the odds of undergoing screening mammography are similar for women with and without visual impairment (VI). Retrospective, longitudinal cohort study. Women aged 65 to 72 years enrolled in fee-for-service Medicare from January 1, 2008, through December 31, 2015. Patients with no vision loss (NVL), partial vision loss (PVL), and severe vision loss (SVL) were matched 1:1:1 based on age, race, time in Medicare, urbanicity of residence, and overall health. Women with pre-existing breast cancer were excluded. Multivariable conditional logistic regression modeling compared the odds of undergoing screening mammography within a 2-year follow-up period among the 3 groups. Proportion of participants undergoing mammography and adjusted odds ratios (ORs) of undergoing mammography within 2 years of follow-up. A total of 1044 patients were matched (348 in each group). The mean ± standard deviation age at the index date was 69.0 ± 1.5 years for all 3 groups. The proportion of women undergoing 1 mammography screening or more withi...Continue Reading

References

Apr 27, 1995·The New England Journal of Medicine·J Blustein
Oct 1, 1995·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·A Colenbrander, D C Fletcher
Dec 24, 1997·Survey of Ophthalmology·A L Coleman, H Morgenstern
Oct 29, 1998·American Journal of Preventive Medicine·J ParkerH W Lawson
Oct 19, 2000·Journal of the American Geriatrics Society·E P McCarthyM A Moskowitz
Jun 7, 2002·Archives of Ophthalmology·Leon B Ellwein, Carol J Urato
Mar 17, 2007·Ethnicity & Health·Ann Scheck McAlearneyElectra D Paskett
Jan 25, 2008·The New England Journal of Medicine·Amal N TrivediJohn Z Ayanian
Nov 19, 2009·Annals of Internal Medicine·UNKNOWN US Preventive Services Task Force
Aug 19, 2011·Journal of Women's Health·Traci LeMasters, Usha Sambamoorthi
May 29, 2012·American Journal of Ophthalmology·April Zambelli-WeinerDavid S Friedman
Jul 3, 2013·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Elena M AndresenLisa I Iezzoni
Jan 21, 2014·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Willi Horner-JohnsonLisa I Iezzoni
Mar 21, 2015·Health Psychology Review·Elizabeth A Sarma
Jan 13, 2016·Annals of Internal Medicine·Albert L Siu, UNKNOWN U.S. Preventive Services Task Force
Jan 14, 2016·Medical Care·Susan A SabatinoFlorence K Tangka
Apr 14, 2016·International Journal for Equity in Health·Wen-Hui FangChing-Hui Loh
Sep 23, 2016·Frontiers in Public Health·Cathy L MelvinChanita Hughes Halbert
Jan 18, 2018·The New England Journal of Medicine·Amal N TrivediIssa J Dahabreh
Apr 5, 2019·JAMA Ophthalmology·Alan R MorseJoshua D Stein

❮ Previous
Next ❯

Citations

May 14, 2021·JAMA Ophthalmology·Qi Zhi Clayton Yang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Medicine
R Smith-BindmanJ Newman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Nancy L KeatingJohn Z Ayanian
JAMA : the Journal of the American Medical Association
Karla KerlikowskeV Ernster
© 2021 Meta ULC. All rights reserved